The Society for Pharmaceutical Dissolution Science (SPDS) conducted its 5th Annual International Convention Disso India-Mumbai 2017 between June 8 and 9, 2017 in Mumbai. The event promoted introduction of new technology, innovation and had deliberations on various issues related to dissolution.
Disso India-Mumbai 2017 witnessed eminent professionals from the pharmaceutical industry and was attended by professionals from R&D, QA and QC as well as the academia.
This event was organised under the chairmanship of Dr. K. Bangarurajan, Deputy Drugs Controller, DDC (India), Central Drugs Standard Control Organization, West Zone and the organizing secretary, Dr. L. Ramaswamy, MD, SOTAX India Pvt Ltd.
The scientific sessions were programmed and executed under the chairmanship of Prof. Padma V. Devarajan, Professor in Pharmacy, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology and Dr. Vinod P. Shah, Ex. US FDA, Pharmaceutical Consultant, USA.
The event comprised of plenary lecture, panel discussion, exhibits and poster session. Disso India 2017 had exceptional global speakers who spoke on subjects such as regulation science: the paradigm of dissolution by Dr. Roger Willam, EX-CEO USP, Ex US FDA, USA, Scientific basis for Topical drug Classification System (TCS) by Dr. Vinod P. Shah, Ex. US FDA, Pharmaceutical Consultant, USA, GI physiology and need for selective dissolution media by Prof. Dr. Jennifer Dressman, Institute of Pharmaceutical Technology, Biocenter, Johann Wolfgang Goethe University, Germany, Advantages and impact of Biorelevant Dissolution Media by Prof. Dr. Jennifer Dressman, Institute of Pharmaceutical Technology, Biocenter, Johann Wolfgang Goethe University, Germany, QbD in Dissolution - Case studies by Vijay Kshirsagar, Director and CEO, TRAC Pharma Consulting, Mumbai, India, Role of Dissolution in evaluating stability and lifespan of the formulation by Dr. Saranjit Singh, Professor & Head, Pharmaceutical Analysis, NIPER and Patentability of a product based on Disso data by Prof. Dr. Umesh Banakar, Professor and President, Banakar Consulting Services, USA. Quality Metrics for better compliance by Prof. Dr. Raghunandan H.V, Deputy Director- Academics, JSS University, Mysore, Data Integrity issues in Dissolution based factors affecting bioavailability by Prof. Dr. Umesh Banakar, Professor and President, Banakar Consulting Services, USA, Automation in Dissolution testing by Michel Magnier, Product Manager and Application specialist, SOTAX AG, Switzerland, Complexity of invitro drug release measurements for ophthalmic drug products by Dr. Chetan Pujara, Vice President, Small Molecule Product Development, Allergan, USA, Drug dissolution: Excipient vs Excipient by Dr. Abhijit V Gothoskar, Technical Advisor, Anshul Life Sciences, India, Risk Assessment of Analytical Methods w.r.t dissolution testing by Manu Grover, Waters India Pvt Ltd, India, Incorporating physiologically based pharmacokinetic (PBPK) modeling to assist with dissolution method development, IVIVC and successful biowaivers by Dr. (Mrs) Parizad A Elchidana, GMP Scientific Inc.